Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Robertson

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
The American Journal of Pathology|April 26, 2007
Mig-7 linked to vasculogenic mimicryGavin P Robertson
Cancer Metastasis Reviews|June 30, 2005
Functional and therapeutic significance of Akt deregulation in malignant melanomaGavin P Robertson
Current Protocols in Pharmacology|September 28, 2011
Models of melanoma metastasis: using a transient siRNA-based protein inhibition strategy in mice to validate the functional relevance of pharmacological agentsArati Sharma, Gavin P Robertson
Expert Opinion on Therapeutic Targets|January 10, 2017
Targeting protein kinase-b3 (akt3) signaling in melanomaSubbaRao V Madhunapantula, Gavin P Robertson
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Chemoprevention of melanomaSubbarao V Madhunapantula, Gavin P Robertson
Enzyme Research|April 5, 2011
Therapeutic Implications of Targeting AKT Signaling in MelanomaSubbarao V Madhunapantula, Gavin P Robertson
Molecular Diagnosis & Therapy|December 4, 2013
Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potentialBrigid S Mumford, Gavin P Robertson
Pigment Cell & Melanoma Research|July 4, 2015
Therapeutic interventions to disrupt the protein synthetic machinery in melanomaGregory R Kardos, Gavin P Robertson
Pigment Cell & Melanoma Research|June 5, 2009
The PTEN-AKT3 signaling cascade as a therapeutic target in melanomaSubbarao V Madhunapantula, Gavin P Robertson
Cancer Biology & Therapy|February 2, 2011
Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expressionPaul J Mosca, Gavin P Robertson
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
The American Journal of Pathology|April 26, 2007
Mig-7 linked to vasculogenic mimicryGavin P Robertson
Cancer Metastasis Reviews|June 30, 2005
Functional and therapeutic significance of Akt deregulation in malignant melanomaGavin P Robertson
Current Protocols in Pharmacology|September 28, 2011
Models of melanoma metastasis: using a transient siRNA-based protein inhibition strategy in mice to validate the functional relevance of pharmacological agentsArati Sharma, Gavin P Robertson
Expert Opinion on Therapeutic Targets|January 10, 2017
Targeting protein kinase-b3 (akt3) signaling in melanomaSubbaRao V Madhunapantula, Gavin P Robertson
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Chemoprevention of melanomaSubbarao V Madhunapantula, Gavin P Robertson
Enzyme Research|April 5, 2011
Therapeutic Implications of Targeting AKT Signaling in MelanomaSubbarao V Madhunapantula, Gavin P Robertson
Molecular Diagnosis & Therapy|December 4, 2013
Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potentialBrigid S Mumford, Gavin P Robertson
Pigment Cell & Melanoma Research|July 4, 2015
Therapeutic interventions to disrupt the protein synthetic machinery in melanomaGregory R Kardos, Gavin P Robertson
Pigment Cell & Melanoma Research|June 5, 2009
The PTEN-AKT3 signaling cascade as a therapeutic target in melanomaSubbarao V Madhunapantula, Gavin P Robertson
Cancer Biology & Therapy|February 2, 2011
Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expressionPaul J Mosca, Gavin P Robertson
Pageof 12